Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196)
China flag China · Delayed Price · Currency is CNY
27.40
+0.55 (2.05%)
Nov 20, 2024, 11:30 AM CST

Shanghai Fosun Pharmaceutical (Group) Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
65,07561,59286,922113,862125,79165,086
Upgrade
Market Cap Growth
-5.62%-29.14%-23.66%-9.48%93.27%12.32%
Upgrade
Enterprise Value
96,11189,228110,109134,998147,71786,903
Upgrade
Last Close Price
27.2924.7434.3547.0851.6425.26
Upgrade
PE Ratio
34.8827.8024.0225.5236.1319.49
Upgrade
Forward PE
23.2321.4819.3620.4330.6817.62
Upgrade
PS Ratio
1.761.491.982.924.152.28
Upgrade
PB Ratio
1.531.091.612.352.741.66
Upgrade
P/TBV Ratio
2.822.883.995.836.404.35
Upgrade
P/OCF Ratio
16.8018.0420.6128.9148.7620.20
Upgrade
PEG Ratio
1.021.021.021.022.050.89
Upgrade
EV/Sales Ratio
2.312.162.513.464.873.04
Upgrade
EV/EBITDA Ratio
16.8123.2519.8732.2736.1823.64
Upgrade
EV/EBIT Ratio
40.0875.3432.1953.2256.4236.52
Upgrade
EV/FCF Ratio
-464.43-----
Upgrade
Debt / Equity Ratio
0.590.620.560.530.520.56
Upgrade
Debt / EBITDA Ratio
6.088.545.255.865.635.74
Upgrade
Asset Turnover
0.370.380.440.440.380.39
Upgrade
Inventory Turnover
2.843.013.763.823.033.20
Upgrade
Quick Ratio
0.680.730.780.750.710.89
Upgrade
Current Ratio
0.921.001.061.041.011.17
Upgrade
Return on Equity (ROE)
4.79%5.23%7.70%10.55%9.25%10.28%
Upgrade
Return on Assets (ROA)
1.33%0.67%2.13%1.79%2.05%2.03%
Upgrade
Return on Capital (ROIC)
1.64%0.84%2.70%2.21%2.50%2.52%
Upgrade
Earnings Yield
2.87%3.87%4.29%4.15%2.91%5.10%
Upgrade
FCF Yield
-0.29%-3.12%-1.92%-0.91%-1.48%-1.14%
Upgrade
Dividend Yield
0.99%1.09%1.22%1.19%0.83%1.54%
Upgrade
Payout Ratio
97.52%102.89%63.64%40.48%50.09%56.13%
Upgrade
Buyback Yield / Dilution
-0.42%-2.40%-1.74%---1.57%
Upgrade
Total Shareholder Return
0.57%-1.31%-0.51%1.19%0.83%-0.03%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.